The 2024 Lasker-Bloomberg Public Service Award, known to many as “America’s Nobel,” went to husband-and-wife HIV researchers Salim Abdool Karim, PhD, and Quarraisha Abdool Karim, PhD. The couple are professors at Columbia University as well as public health advocates. The prize carries a $250,000 stipend. The epidemiologists...

To combat HIV disparities and promote awareness among students at historically black colleges and universities (HBCUs), Alabama State University partnered with ViiV Healthcare to bring HIV education directly to campus throughout its homecoming weekend. “The reason we haven’t ended the epidemic is because of health disparities,” Bithiah Lafontant, ViiV’s director...

In September, the Department of Health and Human Services updated its Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents With HIV. Several revisions were made and new sections were added related to HIV treatment, associated comorbidities and considerations for specific populations. Antiretroviral Therapy. One key change to...

The needs of older people living with HIV are going unmet, and the United States is unlikely to reach five goals for improving quality of life for those ages 50 and older by 2025, according to a Centers for Disease Control and Prevention (CDC) analysis published in Morbidity and Mortality Weekly Report.

The Centers for Disease Control and Prevention (CDC) has announced the five health departments that will receive federal funding to provide generic pre-exposure prophylaxis (PrEP) to prevent HIV as part of a pilot program, according to a joint press statement by four PrEP advocacy groups. Each will receive about $2 million.

New NIAID-supported science presented at the 2024 HIV Research for Prevention (HIVR4P) conference in Lima, Peru features a breadth of HIV discovery and translational findings and enriches the evidence base on HIV pre-exposure prophylaxis (PrEP) within the context of reproductive health. Select Institute-supported science highlights are summarized below. Full HIVR4P abstracts are posted on the official conference web site.

ViiV Healthcare announced today that it will triple the supply of Apretude (long-acting cabotegravir), an injectable form of pre-exposure prophylaxis (PrEP) that is administered every other month. The company will offer at least 2 million doses of long-acting cabotegravir for procurement for low- and middle-income countries during 2025–2026. The announcement was made at the HIVR4P 2024 conference taking place this week in Lima.

Nearly 90% of babies who had to be hospitalized with COVID-19 had mothers who didn’t get the vaccine while they were pregnant, according to new data released by the Centers for Disease Control and Prevention. The findings appear in the agency’s Morbidity and Mortality Weekly Report. Babies too...

Medicare Part B, the federal health insurance for people 65 and older or with certain disabilities, now covers pre-exposure prophylaxis (PrEP) and related services for folks at risk of getting HIV. PrEP as HIV prevention is available as daily tablets and a long-acting injectable. Medicare will cover both. What’s more,...

Gilead Sciences will work with pharmaceutical manufacturers to produce and sell generic lenacapavir for pre-exposure prophylaxis (PrEP) in 120 resource-limited countries with high HIV incidence rates, the company announced this week. Advocates welcomed the news, but some argue that the agreements should not be limited only to low- and lower-middle-income...

Saturday, September 28, marked the 36th annual AIDS Walk Northwest, which celebrates HIV advocacy, reduces stigma and raises funds for HIV and AIDS research and care. Held in Portland, Oregon, AIDS Walk Northwest (formerly AIDS Walk Portland) commemorates those lost to HIV and AIDS while celebrating life and providing vital resources to the community. Emceed by drag performer and longtime community activist Poison Waters, this year’s walk raised almost $259,000, according to a press release from Cascade AIDS Project (CAP), which has organized the event since 1988.

If you or someone you know may be experiencing a mental health crisis, contact the 988 Suicide & Crisis Lifeline by dialing or texting “988.”. When Pooja Mehta’s younger brother, Raj, died by suicide at 19 in March 2020, she felt “blindsided.”. Raj’s last text message was...

Ohio Republican Sen. JD Vance and Minnesota Democratic Gov. Tim Walz met in an October 1 vice presidential debate hosted by CBS News that was cordial and heavy on policy discussion — a striking change from the September 10 debate between Vice President Kamala Harris and former President Donald Trump.

The NIAID HIV clinical research enterprise has celebrated important scientific advances since awards were made to the current networks in 2020. These achievements include the culminating steps in decades of research that led to approval of the first generation of long-acting medications for HIV prevention—a milestone that raises the standard for any future antiretroviral drug development to levels unimaginable even a decade ago.

Novelist and teacher Tom Spanbauer, who mined his own life for unabashed tales of queer love, heartbreak, shame, family and HIV, died September 21, 2024. He was 78. Spanbauer had been living with HIV since the 1980s and with Parkinson’s disease for the past eight years. According to OregonLive.com, the cause of death was heart failure.

Welcome to the 9th Annual POZ Awards, spotlighting the best representatives of HIV and AIDS in media and culture. The POZ editorial staff selects the nominees, but POZ readers choose the winners. Eligible nominees were active or were presented, published or produced between October 1, 2023, and September 30, 2024.

Welcome to the 9th Annual POZ Awards, spotlighting the best representatives of HIV and AIDS in media and culture. The POZ editorial staff selects the nominees, but POZ readers choose the winners. Eligible nominees were active or were presented, published or produced between October 1, 2023, and September 30, 2024.

Welcome to the 9th Annual POZ Awards, spotlighting the best representatives of HIV and AIDS in media and culture. The POZ editorial staff selects the nominees, but POZ readers choose the winners. Eligible nominees were active or were presented, published or produced between October 1, 2023, and September 30, 2024.

Welcome to the 9th Annual POZ Awards, spotlighting the best representatives of HIV and AIDS in media and culture. The POZ editorial staff selects the nominees, but POZ readers choose the winners. Eligible nominees were active or were presented, published or produced between October 1, 2023, and September 30, 2024.

Welcome to the 9th Annual POZ Awards, spotlighting the best representatives of HIV and AIDS in media and culture. The POZ editorial staff selects the nominees, but POZ readers choose the winners. Eligible nominees were active or were presented, published or produced between October 1, 2023, and September 30, 2024.